SB 197 – Connecticut

Status: Enacted
Year Introduced: 2018

BIOLOGICAL PRODUCTS: Concerns biological products, adds biological products to existing law regarding substitution of generic drugs. Requires that within 48-hours of dispensing that the pharmacist shall inform the prescribing practitioner by facsimile, telephone or electronic transmission of the biosimilar substitution.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found